Nephros share price logo

Nephros

NASDAQ: NEPH

$3.55

+0.03

(+0.85%)

Live

as on

Nephros Stock Performance

as on October 24, 2026 at 6:28 am IST

  • Day's Low

    Day's High

    $3.50
    $3.77
    downward going graph

    1.41%

    Downside

    6.20%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.66
    $6.42
    downward going graph

    24.99%

    Downside

    80.85%

    Upside

    downward going graph

Nephros share price movements today

Previous Close
$3.52
Open
$3.61
Volume
155.9K
Market Cap
$39.0M
Day's Low - High
$3.50 - $3.77
52 Week Low - High
$2.66 - $6.42

Nephros Historical Returns

1 Month Return
-17.95 %
3 Month Return
-6.63 %
1 Year Return
-31.52 %
3 Year Return
+ 101.14 %
5 Year Return
-51.92 %

Nephros Stock Fundamentals & Key Indicators

Check Nephros market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.0M

EPS (TTM)

0.1607

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

4.50%

PE Ratio (TTM)

22.34

Industry PE ratio

2.59

PEG Ratio

0.97

EBITDA

1.8M

Revenue (TTM)

20.7M

Profit Margin

60.31%

Return On Equity TTM

16.20%

Nephros vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nephros with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Neutral$39.0M-51.92%22.3460.31%0.00%
Neutral$34.5B-5.40%23.5861.16%1.00%
StrongBuy$151.2B29.96%51.1567.19%0.00%
Neutral$52.8B-18.89%58.5446.12%2.05%
StrongBuy$47.5BNA41.0625.02%0.00%

Stock Returns calculator for Nephros Stock including INR - Dollar returns

The Nephros stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Nephros investment value today

Current value as on today

₹74,701

Returns

-₹25,299

(-25.3%)

Returns from Nephros Stock

-₹30,934 (-30.93%)

Dollar Impact

₹5,634 (+5.63%)

Analyst Recommendation on Nephros Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Nephros. Average target price of $6.25

Nephros Share Price Target

Get share price movements and forecasts by analysts on Nephros.

What analysts predicted

43.2%UPSIDE

Target Price

$6.25

Current Price

$3.55

Analyzed by

1 Analysts

High

$4.75

Target

$6.25

Low

$4.75

Nephros target price $6.25, a slight upside of 43.2% compared to current price of $3.55. According to 1 analysts rating.

Indian Investors' Interest in Nephros Stock

Search interest for Nephros Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-43% versus previous 30 day period

Nephros Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
3
3
3
4
4
4
4
5
6
Gross Profit
2
1
2
2
3
2
2
2
2
3
Operating Income
0
0
0
0
0
0
0
0
0
1
EBITDA
0
0
0
0
0
0
0
0
0
1
Interest Expense
0
-
-
-
-
0
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
0
0
0
0
0
0
1
Income Tax Expense
-
-
-
0
-
0
0
-
-
0
Net Income
0
0
0
0
0
0
0
0
0
1
Net Profit Margin
62.10%
58.79%
61.09%
63.95%
64.67%
63.25%
61.19%
55.42%
56.87%
66.43%

Nephros Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
5
10
8
10
9
14
14
18
Gross Profit
2
3
6
4
5
4
8
8
11
Operating Income
-2
-3
-3
-4
-3
-4
-1
0
1
EBITDA
-2
-3
-3
-4
-2
-3
-1
0
1
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-3
-3
-4
-2
-4
-1
0
1
Income Tax Expense
-1
0
0
-
-
-
-
0
0
Net Income
0
-3
-3
-4
-4
-7
-1
0
1
Net Profit Margin
60.17%
56.32%
58.87%
57.39%
55.13%
47.43%
59.03%
61.59%
61.13%

Nephros Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
0
0
0
0
0
0
1
Operating Cash Flow
0
0
0
1
0
0
0
0
-1
0
Investing Cash Flow
-
0
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
-
0
0
0
0
0
0
0
Change in Cash
0
0
0
1
0
0
0
0
-1
0

Nephros Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-3
-3
-4
-3
-4
-1
0
1
Operating Cash Flow
0
-3
-2
-6
-1
-3
0
0
1
Investing Cash Flow
-
0
0
0
0
0
0
0
-
Financing Cash Flow
1
7
2
11
0
0
0
0
0
Change in Cash
1
2
0
4
-1
-3
0
0
1

Global Institutional Holdings in Nephros

Check out the Institutions with significant holdings in Nephros.

Funds
Holdings
Charles Davidson
33.12%
VANGUARD INDEX FUNDS
1.83%
Vanguard
1.83%
Fidelity Concord Street Trust
0.50%
iShares
0.15%

Insights on Nephros

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 62.0K → 1.19M (in $), with an average increase of 72.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NEPH has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NEPH stock has moved up by 23.9%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 4.72M → 6.01M (in $), with an average increase of 11.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Becton, Dickinson and Co. has given 7.4% return, outperforming this stock by 38.9%

About Nephros

Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, actionable data regarding waterborne pathogens. Furthermore, under its Renal Products segment, the company provides medical devices designed for individuals suffering from renal disease, notably including a second-generation hemodiafiltration system tailored for patients with end-stage renal disease. Additionally, Nephros markets a range of water filters under the Nephros and AETHER brands. These filters are engineered not only to enhance water taste and eliminate odors but also to significantly reduce biofilm, bacteria, and scale accumulation in downstream equipment, serving the food service, hospitality, convenience store, and healthcare industries. Established in 1997, Nephros, Inc. maintains its corporate headquarters in South Orange, New Jersey.
OrganisationNephros
Headquarters380 Lackawanna Place, South Orange, NJ, 07079, US
IndustryMedical - Instruments & Supplies
CEORobert Banks

Key Management of Nephros

Name

Title

Ms. Judy Mazzini

Controller

Mr. Michael Milman

Vice President of R&D

Mr. Robert Banks

President, CEO & Director

Ms. Judy F. Krandel C.F.A.

Chief Financial Officer

Brianne McGuire

Director of Brand, Marketing & Business Development

Vashone R. Thomas

Vice President of Quality, Regulatory, & Human Resources

Mr. Greg Lucas

President of Aether Water Systems

FAQs

What is Nephros share price today?

Nephros share price today is $3.55 as on . Nephros share today touched a day high of $3.77 and a low of $3.50.

What is the 52 week high and 52 week low for Nephros share?

Nephros share touched a 52 week high of $6.42 on and a 52 week low of $2.66 on . Nephros stock price today i.e. is trending at $3.55,which is 44.70% down from its 52 week high and 33.31% up from its 52 week low.

What is Nephros's market capitalisation today?

Nephros market capitalisation is $0.00T as on .

How to invest in Nephros Stock (NEPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nephros on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Nephros Stock (NEPH) from India?

Indian investors can start investing in Nephros (NEPH) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Nephros stock (as per the Rupee-Dollar exchange rate as on ). Based on Nephros share’s latest price of $3.55 as on October 24, 2026 at 12:58 am IST, you will get 2.8169 shares of Nephros. Learn more about fractional shares .

What are the returns that Nephros has given to Indian investors in the last 5 years?

Nephros stock has given -51.92% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?